Evidence map›Paper›PMID 37764142›Full record

ArticleMicroorganisms2023

Killing of a Multispecies Biofilm Using Gram-Negative and Gram-Positive Targeted Antibiotic Released from High Purity Calcium Sulfate Beads.

Kelly Moore, Anthony Li, Niraj Gupta, Tripti Thapa Gupta, Craig Delury, Sean S Aiken, Phillip A Laycock, Paul Stoodley

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kelly MooreDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0002-4139-6086
Anthony LiDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.
Niraj GuptaDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.
Tripti Thapa GuptaDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.
Craig DeluryBiocomposites Ltd., Keele Science Park, Keele, Staffordshire ST5 5NL, UK.
Sean S AikenBiocomposites Ltd., Keele Science Park, Keele, Staffordshire ST5 5NL, UK.
Phillip A LaycockBiocomposites Ltd., Keele Science Park, Keele, Staffordshire ST5 5NL, UK.ORCID 0000-0001-8832-8497
Paul StoodleyDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-6069-273X
The Ohio State University · USUniversity of Southampton · GB

Funding

Biocomposites Ltd Not applicable.
6 · The paper itself

Abstract

backgroundMultispecies biofilm orthopedic infections are more challenging to treat than mono-species infections. In this in-vitro study, we aimed to determine if a multispecies biofilm, consisting of Gram positive and negative species with different antibiotic susceptibilities could be treated more effectively using high purity antibiotic-loaded calcium sulfate beads (HP-ALCSB) containing vancomycin (VAN) and tobramycin (TOB) in combination than alone.

methodsThree sets of species pairs from bioluminescent strains of

resultsThe VAN + TOB bead significantly reduced the PA + EF biofilm CFU and reduced the concentration of surviving antibiotic tolerant variants by 50% compared to single antibiotics.

conclusionsThe combination of Gram-negative and positive targeted antibiotics released from HP-ALCSBs may be more effective in treating multispecies biofilms than monotherapy alone.

Indexed as

biofilmcalcium sulfatemultispecies infectionorthopedic infection

Identifiers

PMID37764142
PMCPMC10538001
OpenAlexW4386628856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.